BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Inhibikase Therapeutics\, Inc. (IKT) investor events
X-WR-CALNAME:Inhibikase Therapeutics\, Inc. (IKT) investor events
DESCRIPTION:Earnings calls and investor events for Inhibikase Therapeutics\
 , Inc. (IKT)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Inhibikase Therapeutics
 \, Inc. (IKT)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:793911a3-6b08-4a94-abf7-9831641e2808@equibles.com
DTSTAMP:20260617T191055Z
DTSTART;VALUE=DATE:20260326
DTEND;VALUE=DATE:20260327
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibikase Therapeutics\, Inc. (IKT) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.\nWebcast: https://event.
 summitcast.com/view/avibSrFufLKeoLRAEgMxy6/guest_book?session_id=d5bicanSb
 kYue3Ub8Mdv9h
URL:https://equibles.com/stocks/ikt/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:d857106f-1ec8-43a1-b080-9d07349997df@equibles.com
DTSTAMP:20260617T190838Z
DTSTART;VALUE=DATE:20260512
DTEND;VALUE=DATE:20260513
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibikase Therapeutics\, Inc. (IKT) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/ikt/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:911af053-fe75-48d2-bfc8-9a886bee9e9e@equibles.com
DTSTAMP:20261024T081449Z
DTSTART:20260626T200000Z
DTEND:20260626T210000Z
SEQUENCE:25604089
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibikase Therapeutics\, Inc. (IKT) Annual General Meeting: 2026 A
 nnual Meeting of Stockholders
DESCRIPTION:2026 Annual Meeting of Stockholders\nWebcast: https://www.inhib
 ikase.com/investors/news-events/events/detail/9130/2026-annual-meeting-of-
 stockholders
END:VEVENT
BEGIN:VEVENT
UID:db4759ab-d199-495e-bf47-51a539ad179c@equibles.com
DTSTAMP:20260811T201210Z
DTSTART;VALUE=DATE:20260811
DTEND;VALUE=DATE:20260812
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibikase Therapeutics\, Inc. (IKT) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/ikt/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:cf48ccf2-f590-4536-acd4-5f5b0d84e4dd@equibles.com
DTSTAMP:20261110T214540Z
DTSTART;VALUE=DATE:20261110
DTEND;VALUE=DATE:20261111
SEQUENCE:27121540
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibikase Therapeutics\, Inc. (IKT) Earnings Call\, FY2026 Q3
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/ikt/calls/2026-q3
END:VEVENT
BEGIN:VEVENT
UID:d03b8f42-4a9b-4a3d-8df4-cf0d5f805547@equibles.com
DTSTAMP:20261028T062800Z
DTSTART:20261116T150000Z
DTEND:20261116T160000Z
SEQUENCE:25943280
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibikase Therapeutics\, Inc. (IKT) Conference: Jefferies Global H
 ealthcare Conference
DESCRIPTION:Jefferies Global Healthcare Conference\nWebcast: https://www.in
 hibikase.com/investors/news-events/events/detail/9195/jefferies-global-hea
 lthcare-conference
URL:https://equibles.com/stocks/ikt/events/d03b8f42-4a9b-4a3d-8df4-cf0d5f80
 5547
END:VEVENT
BEGIN:VEVENT
UID:c788d9f4-8a29-42c3-8d40-0dfb67d27fc7@equibles.com
DTSTAMP:20261028T062800Z
DTSTART;VALUE=DATE:20261202
DTEND;VALUE=DATE:20261203
SEQUENCE:25943280
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibikase Therapeutics\, Inc. (IKT) Conference: 9th Annual Evercor
 e Healthcare Conference
DESCRIPTION:9th Annual Evercore Healthcare Conference\nThe start time has n
 ot been announced.\nWebcast: https://www.inhibikase.com/investors/news-eve
 nts/events/detail/9196/9th-annual-evercore-healthcare-conference
URL:https://equibles.com/stocks/ikt/events/c788d9f4-8a29-42c3-8d40-0dfb67d2
 7fc7
END:VEVENT
END:VCALENDAR
